Matthew (Matt) Shields was appointed Executive Vice President, Teva Global Operations (TGO) in June 2024.

Matt leads one of the largest and most fully integrated manufacturing and supply networks in the pharmaceutical industry. Each day, TGO colleagues are committed to a common goal, delivering a reliable supply of high-quality innovative medicines, affordable generics and biopharmaceuticals to millions of patients.

With more than 25 years of experience serving in various senior management roles in the global pharmaceutical industry, Matt brings to Teva a passion for improving the lives of patients by enabling a purpose-driven culture focused on operational excellence.

Matt has significant experience at every stage of the manufacturing and supply process. Prior to joining Teva, he served as Senior Vice President, for Manufacturing at Merck Animal Health (known as MSD Animal Health outside of the United States and Canada), where he oversaw end-to-end manufacturing, supply chain, procurement, and process development. Prior to Merck Animal Health, he served in various operations leadership roles for Sanofi and Amgen, Inc.

Matt holds an undergraduate degree in Chemical Engineering & Materials Science Engineering from the University of Connecticut and an MBA from Bryant University in Rhode Island.